Different hypotheses such as the activation of cell growth signaling pathways like the PIK3A/Akt/mTOR pathway, the overexpression of EGFR or the activation of the RAS-MEK-MAPK pathway have been the subject of research in breast cancer and have led to the development of specific treatments. This evidence concerns the gene MAP2K7 and breast cancer.